Monday, May 13, 2024 4:55:53 PM
In the quarterly the company states in black and white no RFI. They also specified validation days. If the submission date isn't when the 150 day clock begins it certainly would be by the initial validation date, a little over one month later.
I don't believe you ask for an extension when you aren't asked for anything more. We all know that regulators don't alway meet their own deadlines, but I believe the 250 day average people discuss about the UK includes products not getting priority review. Les may be using 250 days out of caution, but with no RFI, I still believe in 150 days, the only real question is whether it began on December 20th, on submission, or a little over a month later, on initial validation. I'll believe submission is possible until we're past about May 25th, allowing some time to make the announcement after receiving notice by roughly May 21st.
You can criticize as much as you wish, but this week is still in play until it's over.
Gary
I don't believe you ask for an extension when you aren't asked for anything more. We all know that regulators don't alway meet their own deadlines, but I believe the 250 day average people discuss about the UK includes products not getting priority review. Les may be using 250 days out of caution, but with no RFI, I still believe in 150 days, the only real question is whether it began on December 20th, on submission, or a little over a month later, on initial validation. I'll believe submission is possible until we're past about May 25th, allowing some time to make the announcement after receiving notice by roughly May 21st.
You can criticize as much as you wish, but this week is still in play until it's over.
Gary
Bullish
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
